Shares of Catalent (CTLT) are surging on Friday after the contract pharmaceuticals manufacturer provided an update on its full-year outlook and past-due financials. Catalent stock is up over 17% in early trading, making it the top performer in the S&P 500 on Friday. Meanwhile, the three major indexes are largely flat: the S&P 500 is up 0.2%, [...] The post PBE Offers Exposure to Surging Catalent Stock appeared first on ETF Trends .